In today’s issue of Science, there’s a nice review on protein dynamics by Mittermaier & Kay and a paper on the dynamics and function of a peptidyl carrier protein domain of tyrocidine A synthetase. In their review, Mittermaier & Kay wrote:
Although I’m sure X-ray crystallography will still be widely used to determine the three dimensional structures of proteins in the future, I think we’ll start to hear more about the utility of NMR spectroscopy, especially since there are a number of NIH-funded structural genomics centers that are using NMR spectroscopy to solve protein structures, there are new labeling methods that may make it possible to use NMR to solve the structures of larger proteins, and there are exciting demonstrations of how solid-state NMR can be used to probe the structure and function of membrane proteins.
NMR can also be used to find important biologically active small-molecules/potential drugs – for example, Oltersdorf et al. used NMR to find and optimize a new anti-cancer compound and Forino et al. used a “fragment-based approach” to find a new inhibitor of the lethal factor metalloproteinase from Bacillus anthracis.
Of course, many of these experiments can’t be done on an aging NMR spectrometer. In a recent Nature paper, Dorothee Kern’s group used a Varian 800-MHz spectrometer to examine the dynamics of the prolyl cis–trans isomerase cyclophilin A. 800-MHz spectrometers will need to get a lot cheaper before many laboratories can afford to use them routinely…
Joshua
Joshua Finkelstein (Associate Editor, Nature)
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in